1. Signaling Pathways
  2. Metabolic Enzyme/Protease
    Vitamin D Related/Nuclear Receptor
  3. ROR
  4. RORγ Isoform

RORγ

 

RORγ Related Products (20):

Cat. No. Product Name Effect Purity
  • HY-120210
    XY018
    Antagonist 99.90%
    XY018 is a potent ROR-γ-selective antagonist.
  • HY-19775
    GNE-6468
    Antagonist 99.50%
    GNE-6468 is a highly potent and selective RORγ (RORc) inverse agonist with an EC50 value of 13 nM for HEK-293 cell.
  • HY-103637A
    Vimirogant hydrochloride
    Inhibitor 98.33%
    Vimirogant (VTP-43742) hydrochloride is a potent, selective, and orally active RORγt inhibitor (Ki=3.5 nM; IC50=17 nM).
  • HY-119366
    S18-000003
    Inhibitor 99.26%
    S18-000003 is a potent, selective and orally active inhibitor of retinoic acid receptor-related orphan receptor-gamma-t (RORγt), with an IC50 of <30 nM towards human RORγt in competitive binding assays.
  • HY-131338
    RORγt inverse agonist 13
    Inhibitor 99.22%
    RORγt inverse agonist 13 (Compound 3i) is a potent, orally active and selective RORγt inverse agonist, with improved drug-like properties, with an IC50 of 63.8 nM.
  • HY-138115
    7ß,27-Dihydroxycholesterol
    Activator
    7ß,27-Dihydroxycholesterol (7β, 27-OHC) is a potent and selective activator of RORγt (Ki=120 nM).
  • HY-113345
    Zymostenol
    Agonist
    Zymostenol (5a-Cholest-8-en-3b-ol) is a late-stage precursor in the biosynthesis of cholesterol.
  • HY-139780
    JNJ-61803534
    Inhibitor 99.88%
    JNJ-61803534 is a potent and orally active RORγt inverse agonist with an IC50 of 9.6  nM.
  • HY-133552
    RORγt Inverse agonist 10
    Antagonist 99.13%
    RORγt Inverse agonist 10 is a potent and orally bioavailable RORγt (retinoic acid receptor-related orphan nuclear receptor gamma t) inverse agonist, with an IC50 of 51 nM.
  • HY-136527
    BMS-986251
    Antagonist
    BMS-986251 is an orally active and selective RORγt inverse agonist with an EC50 of 12 nM for RORγt GAL4.
  • HY-126252
    A-9758
    Inhibitor
    A-9758 is a RORγ ligand and a potent, selective RORγt inverse agonist (IC50=5 nM), and exhibits robust potency against IL-17A release.
  • HY-115879
    SHR168442
    Modulator
    SHR168442 is a modulator of retinoid-related orphan receptor gamma (RORγ) with an IC50 value of 0.035 μM.
  • HY-142940
    RORγt modulator 5
    Modulator
    RORγt modulator 5 is a RORγt modulator with a Ki value of <100 nM.
  • HY-120785
    SR1555
    Antagonist
    SR1555 is a specific retinoic acid receptor-related orphan nuclear receptor γ (RORγ) inverse agonist with an IC50 value of 1 μM.
  • HY-142939
    RORγt modulator 4
    Modulator
    RORγt modulator 4 is a RORγt modulator.
  • HY-126037
    (±)-ML 209
    Antagonist
    (±)-ML 209 (compound 4n), a diphenylpropanamide, is a retinoic acid-related orphan receptor RORγ antagonist with an IC50 of 1.1 μM.
  • HY-143271
    RORγt inverse agonist 29
    Inhibitor
    RORγt inverse agonist 29 is a potent, orally active and selective RORγt inverse agonist (IC50: 21 nM).
  • HY-111366
    CD12681
    Agonist
    CD12681 (compound 14) is a potent and selective RORγ inverse agonist with IC50 of 19 nM and 10 nM for RORγ GAL4 and CD4-IL-17 cells, respectively.
  • HY-147533
    RORγt inverse agonist 30
    Antagonist
    RORγt inverse agonist 30 (compound 1) is a potent retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonist with an IC50 value of 46 nM.
  • HY-103637
    Vimirogant
    Inhibitor
    Vimirogant (VTP-43742) is a potent, selective, and orally active RORγt inhibitor (Ki=3.5 nM; IC50=17 nM).